{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:18:40Z","timestamp":1785536320951,"version":"3.56.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s00408-018-0160-4","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T02:00:32Z","timestamp":1536026432000},"page":"745-753","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Initial Riociguat Monotherapy and Transition from Sildenafil to Riociguat in Patients with Idiopathic Pulmonary Arterial Hypertension: Influence on Right Heart Remodeling and Right Ventricular\u2013Pulmonary Arterial Coupling"],"prefix":"10.1007","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4649-5921","authenticated-orcid":false,"given":"Irina N.","family":"Taran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna A.","family":"Belevskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina A.","family":"Saidova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamila V.","family":"Martynyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina E.","family":"Chazova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,4]]},"reference":[{"issue":"5","key":"160_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","volume":"115","author":"GE D\u2019Alonzo","year":"1991","unstructured":"D\u2019Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT (1991) Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 115(5):343\u2013349","journal-title":"Ann Intern Med"},{"key":"160_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.rmed.2017.03.025","volume":"126","author":"S Shapiro","year":"2017","unstructured":"Shapiro S, Torres F, Feldman J, Keogh A, Allard M, Blair C, Gillies H, Tislow J, Oudiz RJ (2017) Clinical and hemodynamic improvements after adding ambrisentan to background PDE5i therapy in patients with pulmonary arterial hypertension exhibiting a suboptimal therapeutic response (ATHENA-1). Respir Med 126:84\u201392. \n                    https:\/\/doi.org\/10.1016\/j.rmed.2017.03.025","journal-title":"Respir Med"},{"issue":"Suppl. 1","key":"160_CR3","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/j.rmed.2016.11.001","volume":"122","author":"MM Hoeper","year":"2017","unstructured":"Hoeper MM, Klinger JR, Benza RL, Simonneau G, Langleben D, Naeije R, Corris PA (2017) Rationale and study design of RESPITE: an open-label, phase 3b study of riociguat in patients with pulmonary arterial hypertension who demonstrate an insufficient response to treatment with phosphodiesterase-5 inhibitors. Respir Med 122(Suppl. 1):S18\u2013S22. \n                    https:\/\/doi.org\/10.1016\/j.rmed.2016.11.001","journal-title":"Respir Med"},{"issue":"3","key":"160_CR4","doi-asserted-by":"publisher","first-page":"pii 1602425","DOI":"10.1183\/13993003.02425-2016","volume":"50","author":"MM Hoeper","year":"2017","unstructured":"Hoeper MM, Simonneau G, Corris PA, Ghofrani HA, Klinger JR, Langleben D, Naeije R, Jansa P, Rosenkranz S, Scelsi L, Gr\u00fcnig E, Vizza CD, Chang M, Colorado P, Meier C, Busse D, Benza RL (2017) RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors. Eur Respir J 50(3):pii 1602425","journal-title":"Eur Respir J"},{"issue":"20","key":"160_CR5","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.110.981738","volume":"123","author":"JP Stasch","year":"2011","unstructured":"Stasch JP, Pacher P, Evgenov OV (2011) Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease. Circulation 123(20):2263\u20132273","journal-title":"Circulation"},{"issue":"4","key":"160_CR6","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1183\/09031936.00114407","volume":"32","author":"RT Schermuly","year":"2008","unstructured":"Schermuly RT, Stasch JP, Pullamsetti SS, Middendorff R, Muller D, Schluter KD, Dingendorf A, Hackemack S, Kolosionek E, Kaulen C, Dumitrascu R, Weissmann N, Mittendorf J, Klepetko W, Seeger W, Ghofrani HA, Grimminger F (2008) Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension. Eur Respir J 32(4):881\u2013891","journal-title":"Eur Respir J"},{"issue":"4","key":"160_CR7","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1056\/NEJM199507273330403","volume":"333","author":"A Giaid","year":"1995","unstructured":"Giaid A, Saleh D (1995) Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 333(4):214\u2013221","journal-title":"N Engl J Med"},{"key":"160_CR8","unstructured":"Bayer AG (2017) Adempas: US prescribing information. \n                    http:\/\/labeling.bayerhealthcare.com\/html\/products\/pi\/Adempas_PI.pdf\n                    \n                  . Accessed Nov 2017"},{"key":"160_CR9","first-page":"3","volume":"3","author":"IE Chazova","year":"2015","unstructured":"Chazova IE, Martynyuk TV, Nakonechnikov SN (2015) Outcomes of the European Society of Cardiology Congress 2015: new version of guidelines for diagnosis and treatment of pulmonary hypertension. Evrazijskij Kardiologicheskij Zhurnal 3:3\u201310","journal-title":"Evrazijskij Kardiologicheskij Zhurnal"},{"issue":"1","key":"160_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Gali\u00e8","year":"2016","unstructured":"Gali\u00e8 N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk NA, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M (2016) 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37(1):67\u2013119","journal-title":"Eur Heart J"},{"issue":"5","key":"160_CR11","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1183\/09031936.05.00075305","volume":"26","author":"MM Hoeper","year":"2005","unstructured":"Hoeper MM, Markevych I, Spiekerkoetter E, Welte T, Niedermeyer J (2005) Goal-oriented treatment and combination therapy for pulmonary arterial hypertension. Eur Respir J 26(5):858\u2013863. \n                    https:\/\/doi.org\/10.1183\/09031936.05.00075305","journal-title":"Eur Respir J"},{"issue":"25 Suppl","key":"160_CR12","doi-asserted-by":"publisher","first-page":"D73","DOI":"10.1016\/j.jacc.2013.10.034","volume":"62","author":"VV McLaughlin","year":"2013","unstructured":"McLaughlin VV, Gaine SP, Howard LS, Leuchte HH, Mathier MA, Mehta S, Palazzini M, Park MH, Tapson VF, Sitbon O (2013) Treatment goals of pulmonary hypertension. J Am Coll Cardiol 62(25 Suppl):D73\u2013D81","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"160_CR13","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1056\/NEJMoa1413687","volume":"373","author":"N Gali\u00e8","year":"2015","unstructured":"Gali\u00e8 N, Barbera JA, Frost AE, Ghofrani HA, Hoeper MM, McLaughlin VV, Peacock AJ, Simonneau G, Vachiery JL, Grunig E, Oudiz RJ, Vonk-Noordegraaf A, White RJ, Blair C, Gillies H, Miller KL, Harris JH, Langley J, Rubin LJ (2015) Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension. N Engl J Med 373(9):834\u2013844","journal-title":"N Engl J Med"},{"issue":"133","key":"160_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.15829\/1560-4071-2016-5-5-64","volume":"5","author":"OM Moiseeva","year":"2016","unstructured":"Moiseeva OM, Goncharova NS (2016) National guidelines for the diagnosis and treatment of pulmonary hypertension. Russ J Cardiol 5(133):5\u201364. \n                    https:\/\/doi.org\/10.15829\/1560-4071-2016-5-5-64","journal-title":"Russ J Cardiol"},{"key":"160_CR15","unstructured":"Bayer AG. Adempas. EU summary of product characteristics. \n                    http:\/\/www.emaeuropaeu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/002737\/WC500165034pdf\n                    \n                  . Accessed June 2018"},{"issue":"4","key":"160_CR16","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1056\/NEJMoa1209655","volume":"369","author":"HA Ghofrani","year":"2013","unstructured":"Ghofrani HA, Gali\u00e8 N, Grimminger F, Grunig E, Humbert M, Jing ZC, Keogh AM, Langleben D, Kilama MO, Fritsch A, Neuser D, Rubin LJ (2013) Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med 369(4):330\u2013340","journal-title":"N Engl J Med"},{"issue":"5","key":"160_CR17","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1183\/09031936.00090614","volume":"45","author":"LJ Rubin","year":"2015","unstructured":"Rubin LJ, Gali\u00e8 N, Grimminger F, Grunig E, Humbert M, Jing ZC, Keogh A, Langleben D, Fritsch A, Menezes F, Davie N, Ghofrani HA (2015) Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2). Eur Respir J 45(5):1303\u20131313","journal-title":"Eur Respir J"},{"key":"160_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S2213-2600(16)30019-4","volume":"4","author":"HA Ghofrani","year":"2016","unstructured":"Ghofrani HA, Grimminger F, Grunig E, Huang Y, Jansa P, Jing ZC, Kilpatrick D, Langleben D, Rosenkranz S, Menezes F, Fritsch A, Nikkho S, Humbert M (2016) Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial. Lancet Respir Med 4:361\u2013371","journal-title":"Lancet Respir Med"},{"issue":"1","key":"160_CR19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/ejechocard\/jen236","volume":"10","author":"F Antonini-Canterin","year":"2009","unstructured":"Antonini-Canterin F, Carerj S, Di Bello V, Di Salvo G, La Carrubba S, Vriz O, Pavan D, Balbarini A, Nicolosi GL, Research Group of the Italian Society of Cardiovascular Echography (SIEC) (2009) Arterial stiffness and ventricular stiffness: a couple of diseases or a coupling disease? A review from the cardiologist\u2019s point of view. Eur J Echocardiogr 10(1):36\u201343. \n                    https:\/\/doi.org\/10.1093\/ejechocard\/jen236","journal-title":"Eur J Echocardiogr"},{"issue":"11","key":"160_CR20","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.echo.2009.08.009","volume":"22","author":"F Antonini-Canterin","year":"2009","unstructured":"Antonini-Canterin F, Enache R, Popescu BA, Popescu AC, Ginghina C, Leiballi E, Piazza R, Pavan D, Rubin D, Cappelletti P, Nicolosi GL (2009) Prognostic value of ventricular-arterial coupling and B-type natriuretic peptide in patients after myocardial infarction: a five-year follow-up study. J Am Soc Echocardiogr 22(11):1239\u20131245. \n                    https:\/\/doi.org\/10.1016\/j.echo.2009.08.009","journal-title":"J Am Soc Echocardiogr"},{"issue":"3","key":"160_CR21","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/heartjnl-2011-300462","volume":"98","author":"J Sanz","year":"2012","unstructured":"Sanz J, Garcia-Alvarez A, Fernandez-Friera L, Nair A, Mirelis JG, Sawit ST, Pinney S, Fuster V (2012) Right ventriculo-arterial coupling in pulmonary hypertension: a magnetic resonance study. Heart 98(3):238\u2013243. \n                    https:\/\/doi.org\/10.1136\/heartjnl-2011-300462","journal-title":"Heart"},{"key":"160_CR22","unstructured":"Belevskaya AA (2017) Assessment of the heart structure and functional status, biventricular interdependence and caridovascular coupling in patients with pulmonary hypertension of various severity. Cand Sci (Med) Dissertation, Moscow"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-018-0160-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-018-0160-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-018-0160-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T19:06:37Z","timestamp":1567537597000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-018-0160-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,4]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["160"],"URL":"https:\/\/doi.org\/10.1007\/s00408-018-0160-4","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,4]]},"assertion":[{"value":"20 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest. This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}